Creatine has long been the darling of gym bros and supplement…
Category: Clinical Trials
Home /
People with a rare genetic form of Alzheimer’s disease can begin…
New research continually adds to our knowledge of the effects of…
Skim the pharma news outlet of your choice, and it’s clear…
Human bodies are home to vast microbial ecosystems. New research from…
Millions of people take glucagon-like peptide-1 (GLP-1) receptor agonists like semaglutide…
Ultraprocessed foods do more than add extra pounds. A new study…
Men with early-stage prostate cancer may have a new tool to…
Intermittent fasting is quickly becoming one of the most popular dietary…
California-based Capsida Biotherapeutics has reported promising preclinical results for CAP-002, its…
Gonorrhea is one of the most widespread sexually transmitted infections, with…
A new contender in the fight against lung cancer has emerged,…
Antibody-drug conjugates (ADCs) are being studied in various diseases, including cancer,…
Prostate cancer is the second most common cancer in men worldwide,…
For individuals with life-threatening food allergies, everyday activities like dining out…
Alnylam Pharmaceuticals, which specializes in developing RNA interference (RNAi) therapeutics to…
Advocates of fasting point to the potential health and longevity benefits,…
As reported in our previous CTIS-related blog post, the way clinical…
The face of clinical trials in the European Union (EU) is…
Marc, a 63-year-old from Bordeaux, France, has lived with Parkinson’s disease…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
Introduction Changes in how clinical trials are managed in the European Union (EU), mandated by the European Union Clinical Trial Regulation 536/2014 (EU CTR),…
TAIPEI, Taiwan—(BUSINESS WIRE)—QPS, a leading global contract research organization (CRO) specializing in preclinical and clinical drug development services, is pleased to announce the expansion…
QPS India has achieved another significant milestone by successfully completing a scheduled inspection by the UK Medicines and Healthcare products Regulatory Agency (MHRA) from…
QPS Selects Ryght AI as an Exclusive AI Partner for Clinical Trial Optimization and Automation while adding to Ryght’s global site network. Laguna Beach,…
Webinars
Creatine’s Muscle Myth: New Study Deflates the Hype
April 21, 2025
Creatine has long been the darling of gym bros and supplement pros. Touted as a muscle-building powerhouse, it’s naturally produced by the liver, pancreas and
Slowing the Clock: Trial Delivers Hope in Delaying Alzheimer’s Disease
April 7, 2025
People with a rare genetic form of Alzheimer’s disease can begin to experience memory loss and dementia starting in their 30s, 40s and 50s. Although
The Food Factor: How Diet Shapes Cancer Risk
March 24, 2025
New research continually adds to our knowledge of the effects of diet on cancer risk. Among recent findings, detailed below, are the protective effects of
Pharma Strikes Back at Compounding Pharmacies
March 12, 2025
Skim the pharma news outlet of your choice, and it’s clear that compounding pharmacies have been making headlines. These pharmacies typically provide one of three
Tracing the Sexome: How Our Bacteria Linger After Sex
March 10, 2025
Human bodies are home to vast microbial ecosystems. New research from Murdoch University in Australia reveals that during sexual contact, individuals exchange unique bacterial communities
Eyeing Potential Risks: Investigating Vision Changes Linked to GLP-1 Drugs
March 3, 2025
Millions of people take glucagon-like peptide-1 (GLP-1) receptor agonists like semaglutide and tirzepatide to manage diabetes and obesity. These drugs have transformed weight loss and
Ultraprocessed Food: How Diet Raises Osteoarthritis Risk
February 24, 2025
Ultraprocessed foods do more than add extra pounds. A new study reveals they also weaken muscles, as fat increases and strength decreases. Even if calorie
Diet Changes to Slow Prostate Cancer? Omega-3 Study Has Promising Results
February 17, 2025
Men with early-stage prostate cancer may have a new tool to help slow disease progression. A Phase II trial led by researchers at the UCLA
An Unintended Consequence of Intermittent Fasting: Reduced Hair Growth
January 15, 2025
Intermittent fasting is quickly becoming one of the most popular dietary adjustments around the world. Less of a “diet” and more of a “dietary pattern,”
Encouraging Preclinical Results Show Gene Therapy Reduces Seizures
January 13, 2025
California-based Capsida Biotherapeutics has reported promising preclinical results for CAP-002, its gene therapy for developmental and epileptic encephalopathy (DEE) caused by mutations in the syntaxin-binding
New Antibiotic Could Simplify Gonorrhea Treatment
November 20, 2024
Gonorrhea is one of the most widespread sexually transmitted infections, with as many as 82 million new infections occurring worldwide each year. While not all
Bispecific Antibody Drug Shows Cancer Treatment Potential
October 7, 2024
A new contender in the fight against lung cancer has emerged, with strong clinical trial results for ivonescimab, a bispecific antibody from partners Akeso and
Advancing Phase 3 Trials for ADC Cancer Therapies
September 25, 2024
Antibody-drug conjugates (ADCs) are being studied in various diseases, including cancer, autoimmune and infectious diseases. In cancer, ADCs are made up of a monoclonal antibody
New Cancer Treatment Modality Goes into Phase I
September 18, 2024
Prostate cancer is the second most common cancer in men worldwide, making the search for effective treatments an urgent imperative for the medical community. Now,
FDA Approves New Drug for Food Allergies
August 21, 2024
For individuals with life-threatening food allergies, everyday activities like dining out and traveling can be tremendously stressful, as even the smallest traces of the allergen
RNAi Breakthrough in Heart Disease Treatment
August 12, 2024
Alnylam Pharmaceuticals, which specializes in developing RNA interference (RNAi) therapeutics to treat genetic diseases, has announced promising clinical trial results for their drug Amvuttra® (vutrisiran)
Going Cold Turkey — How a Week-Long Fast Affects Your Health
July 31, 2024
Advocates of fasting point to the potential health and longevity benefits, often citing results from animal studies. However, the impact of prolonged calorie restriction on
EU Clinical Trial Regulation 536/2014 and CTIS: Common Questions and Answers
March 20, 2024
As reported in our previous CTIS-related blog post, the way clinical trials are documented in the European Union (EU) is changing. By January 31, 2025,
Navigating Changes to EU Clinical Trial Management: What You Need to Know
March 13, 2024
The face of clinical trials in the European Union (EU) is changing. By January 31, 2025, all ongoing clinical trials must move to the Clinical
“It’s Incredible” — Breakthrough Spinal Implant Restores Walking Ability Lost Due to Parkinson’s Disease
February 12, 2024
Marc, a 63-year-old from Bordeaux, France, has lived with Parkinson’s disease for more than two decades. The disease had increasingly hindered his mobility, causing balance
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
Introduction Changes in how clinical trials are managed in the European Union (EU), mandated by the European Union Clinical Trial Regulation 536/2014 (EU CTR),…
TAIPEI, Taiwan—(BUSINESS WIRE)—QPS, a leading global contract research organization (CRO) specializing in preclinical and clinical drug development services, is pleased to announce the expansion…
QPS India has achieved another significant milestone by successfully completing a scheduled inspection by the UK Medicines and Healthcare products Regulatory Agency (MHRA) from…
QPS Selects Ryght AI as an Exclusive AI Partner for Clinical Trial Optimization and Automation while adding to Ryght’s global site network. Laguna Beach,…
